NW BIOTECH INVEST ApS: Financial statements 2012
CVR: 25942167
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NW BIOTECH INVEST ApS (CVR 25942167) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -23,640 and a net result of DKK 4,119,919. Equity in the 2012 report amounted to DKK 1,223,158. The solvency ratio was 19.4%.
- Gross Profit
- DKK -23,640
- Profit/Loss
- DKK 4,119,919
- Equity
- DKK 1,223,158
- Total Assets
- DKK 6,303,967
Official annual report
Keep an eye on NW BIOTECH INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of March 13, 2012, RVT REVISIONSTJENESTEN A/S has been appointed auditor of NW BIOTECH INVEST ApS.
As of March 13, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NW BIOTECH INVEST ApS.
About NW BIOTECH INVEST ApS
NW BIOTECH INVEST ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2001. The company has been dissolved on 10 August 2018. The company was registered under the industry Uoplyst. The company was previously named GFKJUS 637 ApS. In 2013, the company reported a gross profit of DKK -18,983 and a net result of DKK -6,270,866 compared with DKK 4,119,919 the year before. Equity in the 2013 report amounted to DKK -5,047,708.
